
Loading, please wait...

Loading, please wait...

The rapid global rise in vaping has sparked significant medical concern regarding long-term e-cigarette health effects. Although many users view these devices as safer alternatives to combustible tobacco, recent clinical data suggests a more complex reality. Chronic exposure to e-cigarette aerosols may contribute substantially to respiratory and cardiovascular morbidity.
Research synthesis from 2015 to 2025 demonstrates a strong link between frequent vaping and various chronic conditions. Specifically, daily users face elevated risks of Chronic Obstructive Pulmonary Disease (COPD) and asthma exacerbations. Furthermore, clinical evidence indicates impaired lung function and increased instances of myocardial infarction. Arrhythmias and endothelial dysfunction are also common among long-term users. Therefore, physicians must carefully monitor vapers for early signs of cardiopulmonary distress.
The biological pathways underlying these risks involve nicotine-induced sympathetic activation and systemic oxidative stress. Vascular injury occurs due to the toxic components in e-liquids, even in the absence of tobacco combustion. Consequently, older adults show reduced physiological resilience to these stressors. Daily users are particularly vulnerable because they experience cumulative exposure over time. Despite these findings, distinguishing between exclusive vapers and dual users remains a challenge for researchers.
Clinicians should prioritize patient education regarding these emerging risks. Since India has implemented a comprehensive ban on e-cigarettes, identifying illicit use is crucial for preventive care. Future cohort studies will help refine clinical guidance and regulatory policies across the globe.
E-cigarettes trigger sympathetic nervous system activation, leading to higher heart rates and blood pressure. These changes increase the risk of arrhythmias and myocardial infarction over time.
While some toxicant levels are lower, vaping is significantly linked to COPD and asthma. The aerosols cause inflammation and oxidative stress in lung tissues similar to traditional smoking.
Older adults and daily users are at the highest risk. Cumulative exposure combined with reduced physiological resilience makes these groups more susceptible to chronic organ damage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A contemporary review of evidence (2015-2025) exploring the chronic cardiovascular and respiratory consequences of frequent e-cigarette use....
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today